The Library
Combinatorial use of chitosan nanoparticles, reversine, and ionising radiation on breast cancer cells associated with mitosis deregulation
Tools
Piña Olmos, Sofia, Díaz Torres, Roberto, Elbakrawy, Eman, Hughes, Louise, McKenna, Joseph F., Hill, Mark A., Kadhim, Munira, Ramírez Noguera, Patricia and Bolanos-Garcia, Victor M. (2019) Combinatorial use of chitosan nanoparticles, reversine, and ionising radiation on breast cancer cells associated with mitosis deregulation. Biomolecules, 9 (5). 186. doi:10.3390/biom9050186 ISSN 2218-273X.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.3390/biom9050186
Abstract
Breast cancer is the most commonly occurring cancer in women worldwide and the second most common cancer overall. The development of new therapies to treat this devastating malignancy is needed urgently. Nanoparticles are one class of nanomaterial with multiple applications in medicine, ranging from their use as drug delivery systems and the promotion of changes in cell morphology to the control of gene transcription. Nanoparticles made of the natural polymer chitosan are easy to produce, have a very low immunogenic profile, and diffuse easily into cells. One hallmark feature of cancer, including breast tumours, is the genome instability caused by defects in the spindle-assembly checkpoint (SAC), the molecular signalling mechanism that ensures the timely and high-fidelity transmission of the genetic material to an offspring. In recent years, the use of nanoparticles to treat cancer cells has gained momentum. This is in part because nanoparticles made of different materials can sensitise cancer cells to chemotherapy and radiotherapy. These advances prompted us to study the potential sensitising effect of chitosan-based nanoparticles on breast cancer cells treated with reversine, which is a small molecule inhibitor of Mps1 and Aurora B that induces premature exit from mitosis, aneuploidy, and cell death, before and after exposure of the cancer cells to X-ray irradiation. Our measurements of metabolic activity as an indicator of cell viability, DNA damage by alkaline comet assay, and immunofluorescence using anti-P-H3 as a mitotic biomarker indicate that chitosan nanoparticles elicit cellular responses that affect mitosis and cell viability and can sensitise breast cancer cells to X-ray radiation (2Gy). We also show that such a sensitisation effect is not caused by direct damage to the DNA by the nanoparticles. Taken together, our data indicates that chitosan nanoparticles have potential application for the treatment of breast cancer as adjunct to radiotherapy.
Item Type: | Journal Article | ||||||
---|---|---|---|---|---|---|---|
Divisions: | Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- ) | ||||||
Journal or Publication Title: | Biomolecules | ||||||
Publisher: | MDPI | ||||||
ISSN: | 2218-273X | ||||||
Official Date: | 12 May 2019 | ||||||
Dates: |
|
||||||
Volume: | 9 | ||||||
Number: | 5 | ||||||
Article Number: | 186 | ||||||
DOI: | 10.3390/biom9050186 | ||||||
Status: | Peer Reviewed | ||||||
Publication Status: | Published | ||||||
Access rights to Published version: | Open Access (Creative Commons) |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |